ネブライザーの市場規模、シェア、成長分析：タイプ別、モダリティ別、用途別、最終用途別、地域別 - 産業予測 2025年～2032年

ネブライザー市場規模は2023年に12億3,000万米ドル、予測期間（2025-2032年）のCAGRは6.1%で、2024年の13億1,000万米ドルから2032年には21億米ドルに成長する見通しです。

ネブライザー市場は、慢性呼吸器疾患の有病率の上昇、在宅ヘルスケア需要の増加、高齢化などいくつかの要因によって力強い成長を遂げています。特に慢性閉塞性肺疾患（COPD）は、米国における死因の第4位にランクされており、その主な原因はタバコや加工品の消費などの生活習慣によるものです。CDCの報告によると、北米の30～70歳の成人の死因の約14％がタバコの使用に関連しており、呼吸器疾患とネブライザーの需要との関連性が強調されています。世界全体では、COPDによる死亡者数は約323万人であるが、「慢性呼吸器疾患に対する世界・アライアンス」のような取り組みにより、診断と治療が強化され、ネブライザー市場の成長性がさらに高まると期待されています。

目次

イントロダクション

• 調査の目的
• 調査範囲
• 定義

調査手法

• 情報調達
• 二次データと一次データの方法
• 市場規模予測
• 市場の前提条件と制限

エグゼクティブサマリー

• 世界市場の見通し
• 供給と需要の動向分析
• セグメント別機会分析

市場力学と見通し

• 市場概要
• 市場規模
• 市場力学
  • 促進要因と機会
  • 抑制要因と課題
• ポーターの分析

主な市場の考察

• 重要成功要因
• 競合の程度
• 主な投資機会
• 市場エコシステム
• 市場の魅力指数（2024年）
• PESTEL分析
• マクロ経済指標
• バリューチェーン分析
• 価格分析

ネブライザー市場規模：タイプ別& CAGR（2025-2032）

• 市場概要
• ジェット
• メッシュ
  • アクティブ
  • パッシブ
• 超音波

ネブライザー市場規模：モダリティ別& CAGR（2025-2032）

• 市場概要
• ポータブル
• テーブルトップ

ネブライザー市場規模：用途別& CAGR（2025-2032）

• 市場概要
• 慢性閉塞性肺疾患
• 嚢胞性線維症
• 喘息
• その他

ネブライザー市場規模：最終用途別& CAGR（2025-2032）

• 市場概要
• 病院と診療所
• 緊急センター
• 在宅ヘルスケア

ネブライザー市場規模：地域別& CAGR（2025-2032）

• 北米
  • 米国
  • カナダ
• 欧州
  • ドイツ
  • スペイン
  • フランス
  • 英国
  • イタリア
  • その他欧州地域
• アジア太平洋地域
  • 中国
  • インド
  • 日本
  • 韓国
  • その他アジア太平洋地域
• ラテンアメリカ
  • ブラジル
  • その他ラテンアメリカ地域
• 中東・アフリカ
  • GCC諸国
  • 南アフリカ
  • その他中東・アフリカ

競合情報

• 上位5社の比較
• 主要企業の市場ポジショニング（2024年）
• 主な市場企業が採用した戦略
• 市場の最近の動向
• 企業の市場シェア分析（2024年）
• 主要企業の企業プロファイル
  • 会社概要
  • 製品ポートフォリオ分析
  • セグメント別シェア分析
  • 収益の前年比比較（2022-2024）

主要企業プロファイル

• Omron Corporation（Japan）
• Allied Healthcare（United Kingdom）
• Teleflex Incorporated（United States）
• Briggs Healthcare（United States）
• Aerogen（Ireland）
• Medtronic Plc（Ireland）
• GE Healthcare（United States）
• DeVilbiss Healthcare LLC（United States）
• Koninklijke Philips N.V.（Netherlands）
• Vectura Group Plc.（United Kingdom）
• PARI Respiratory Equipment, Inc.（Germany）
• Beurer GmbH（Germany）
• Covidien plc（Ireland）
• Becton, Dickinson and Company（BD）（United States）
• Rossmax International Ltd.（Taiwan）
• Nulife Global Medical Devices（India）
• BPL Medical Technologies（India）
• Agaro（India）
• Medline Industries, LP（United States）
• Drive DeVilbiss Healthcare（United States）

結論と推奨事項

Nebulizer Market size was valued at USD 1.23 billion in 2023 and is poised to grow from USD 1.31 billion in 2024 to USD 2.1 billion by 2032, growing at a CAGR of 6.1% during the forecast period (2025-2032).

The Nebulizer market is experiencing robust growth driven by several factors including the rising prevalence of chronic respiratory diseases, increased demand for home healthcare, and an aging population. Chronic Obstructive Pulmonary Disease (COPD) is particularly concerning, ranking as the fourth leading cause of death in the U.S., largely due to lifestyle factors like tobacco and processed product consumption. The CDC reports that around 14% of deaths in adults aged 30-70 in North America are related to tobacco use, emphasizing the link between respiratory diseases and nebulizer demand. Globally, COPD accounts for approximately 3.23 million deaths, but initiatives like the "Global Alliance against Chronic Respiratory Diseases" are expected to enhance diagnosis and treatment, further boosting the nebulizer market's growth potential.

Top-down and bottom-up approaches were used to estimate and validate the size of the Nebulizer market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Nebulizer Market Segments Analysis

Global Nebulizer Market is segmented by Type, Modality, Application, End-use and region. Based on Type, the market is segmented into Jet, Mesh and Ultrasonic. Based on Modality, the market is segmented into Portable and Table-top. Based on Application, the market is segmented into COPD, Cystic Fibrosis, Asthma and Others. Based on End-use, the market is segmented into Hospitals And Clinics, Emergency Centers and Home Healthcare. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Nebulizer Market

The increasing prevalence of respiratory ailments, including asthma, chronic obstructive pulmonary disease (COPD), and cystic fibrosis, serves as a major driver for the nebulizer market. These health conditions necessitate efficient medication delivery systems to effectively reach the respiratory tract, making nebulizers an essential tool in administering treatments directly to the lungs. As more individuals are diagnosed with these diseases, the demand for nebulizers continues to rise, further boosting the market's growth. This trend highlights the critical role that nebulizers play in enhancing patient care and improving respiratory health outcomes, thereby solidifying their position in the healthcare industry.

Restraints in the Nebulizer Market

The nebulizer market faces significant restraints due to the limitations and inconsistencies in reimbursement policies for nebulizer treatments. This inadequacy in comprehensive coverage can hinder both affordability and accessibility, making it challenging for patients to acquire the necessary nebulizer devices and medications. As a result, many patients encounter obstacles when seeking nebulizer therapy, which ultimately restricts the overall growth potential of the market. Without reliable reimbursement options, the demand for nebulizers may stagnate, impacting manufacturers and healthcare providers alike. Such barriers must be addressed to foster a more supportive environment for both patients and the nebulizer market as a whole.

Market Trends of the Nebulizer Market

The nebulizer market is witnessing a significant trend towards technological innovation, characterized by the increasing adoption of mesh nebulizers that leverage advanced vibrating mesh technology. This shift has resulted in devices that not only deliver medications more efficiently but are also compact and portable, catering to the growing demand for convenience among users. As drug delivery systems evolve, these improvements are enhancing the overall patient experience by minimizing drug loss and optimizing treatment outcomes. Additionally, the rise in respiratory diseases and the focus on personalized healthcare solutions are expected to further drive market growth, making nebulizers a vital component of modern respiratory therapy.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2024
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis

Global Nebulizer Market Size by Type & CAGR (2025-2032)

• Market Overview
• Jet
• Mesh
  • Active
  • Passive
• Ultrasonic

Global Nebulizer Market Size by Modality & CAGR (2025-2032)

• Market Overview
• Portable
• Table-top

Global Nebulizer Market Size by Application & CAGR (2025-2032)

• Market Overview
• COPD
• Cystic Fibrosis
• Asthma
• Others

Global Nebulizer Market Size by End-use & CAGR (2025-2032)

• Market Overview
• Hospitals And Clinics
• Emergency Centers
• Home Healthcare

Global Nebulizer Market Size & CAGR (2025-2032)

• North America (Type, Modality, Application, End-use)
  • US
  • Canada
• Europe (Type, Modality, Application, End-use)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Type, Modality, Application, End-use)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Type, Modality, Application, End-use)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Type, Modality, Application, End-use)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2024
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2024
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

• Omron Corporation (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Allied Healthcare (United Kingdom)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Teleflex Incorporated (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Briggs Healthcare (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Aerogen (Ireland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Medtronic Plc (Ireland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• GE Healthcare (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• DeVilbiss Healthcare LLC (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Koninklijke Philips N.V. (Netherlands)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Vectura Group Plc. (United Kingdom)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• PARI Respiratory Equipment, Inc. (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Beurer GmbH (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Covidien plc (Ireland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Becton, Dickinson and Company (BD) (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Rossmax International Ltd. (Taiwan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Nulife Global Medical Devices (India)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• BPL Medical Technologies (India)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Agaro (India)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Medline Industries, LP (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Drive DeVilbiss Healthcare (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations